Cytodyn Inc (CYDY)

[stockorus]

without compensation

That's the magic phrase. Dr. Jay is setting an example here, and showing his belief in Leronlimab's potential and wanting its success.

All the same, this does not look like a company about to die. Rather they are taking a step back and identifying the landscape where LL can make its mark, and re-focusing. I don't know how they can achieve it inspite of the financial gloom and doom that shorts project; but somehow they are looking forward and showing confidence. These people they have added most likely after extensive discussions on data and results with them. The company knows at this point there is practically no room to take anything lightly and do things just because.